Although antibody-drug conjugates and protein therapeutics now play a significant role in the treatment and diagnosis of diseases, this field is continuously evolving with novel and innovative next-generation therapeutics on the horizon. Therefore, we invite you to attend the 6th Antibody & Protein Therapeutics Summit to be held in Boston, MA. The summit is the ideal venue to network with academic and pharmaceutical industry scientists, providing access to over 40 presentations from leading experts and will feature the latest advances in antibody and protein therapeutic research, including clinical findings.
This summit is comprised of three complimentary topics that seek to drive the discovery, development and application of antibody & protein therapies. Track 1 – Antibodies in Oncology & Beyond will provide sessions exploring antibody discovery strategies and the development of antibodies and proteins for cancer immunotherapy and infectious diseases. Track 2 – Antibody Drug Conjugates will provide numerous sessions spanning basic discovery and development to important clinical findings. Track 3 – Novel Protein Therapeutics will provide innovative ideas in protein design and engineering. The sessions will also highlight advances in emerging antigen discovery in disease and applications with radioactive payloads.
Join us to network with colleagues to discuss the methods and tools used in developing effective next-generation antibody-drug conjugates and protein therapeutics to “drive the future of science.”
We hope to see you there!
The 2018 Advisory Committee
Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
Wyatt Technology is the recognized leader in instrumentation for determining the absolute molar mass, size, charge and interactions of macromolecules and nanoparticles in solution. These tools include: in-line multi-angle static light scattering, high-throughput dynamic light scattering, differential refractometry, electrophoretic mobility, differential viscosity, field flow fractionation and automated composition gradient.
Viracor Eurofins provides clinical trial biomarker testing services with expertise in custom assay transfer, design and validation for phase I-IV trials. Our CAP/CLIA and NY state accredited laboratory has over 30 years of experience in molecular testing, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing.